Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio (A:NYSE)

Agilent to acquire Biocare Medical for $950M cash, expanding its pathology portfolio.

You will be redirected in 10 seconds.

liveinternet liveinternet